Immunisation Practices News Today

Streptococcus pneumoniae infection is a common cause of pneumonia in adults. Vaccines have helped reduce some strains, but new ones have emerged, leading to the development of three recommended vaccines: PCV15, PCV20, and PPSV23. Recently, CDC’s Advisory Committee on Immunisation Practices (ACIP) updated the new pneumococcal vaccination guideline.

Ixchiq, the world's first chikungunya vaccine, has the potential to mitigate a major public health threat, and prevent millions of cases of chikungunya worldwide, according to a report on Thursday.The vaccine, developed by French biotech ...

A biopharmaceutical company, Pfizer, has partnered the University College Hospital (UCH), Ibadan to enhance the quality of care provided to patients and ensure global best practices. Mr Olayinka Subair, Cluster Lead for West Africa/Country Manager Nigeria, Pfizer, made the disclosure in a statement on Monday in Lagos. Subair said that UCH had decided to formulate

Updated vaccines recommended by US CDC target the currently circulating Covid-19 variants

The independent vaccine advisers of the US Centers for Disease Control and Prevention voted 13-1 to recommend updated COVID-19 vaccines for all Americans aged 6 months and older. These...

Yascha Mounk’s new book mounts a defence of liberalism against its foes on Left and Right – but is the ideology its own worst enemy?

Hospitalisations are up over 40pc from recent lows hit in June but are still more than 90pc below peak levels hit during January 2022 Omicron outbreak.

Pfizer annual revenue is expected to reach $101.3bn in 2022, thanks to its COVID-19 vaccine and Paxlovid, an ineffective antiviral.

The ACIP voted unanimously to add Pfizer and Moderna COVID-19 vaccines for children from 6 months old to the new Child and Adolescent Immunisation Schedules.

Last month, the FDA authorised omicron-specific vaccines, accompanied by breathless science-by-press release and a media blitz. Just days after the FDA’s move, the Centers for Disease Control and Prevention followed, recommending updated boosters for anyone age 12 and up who had received at least two doses of the